Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 11Glioblastoma 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Lung Neoplasms 2Recurrence 1Neurotoxicity Syndromes 1Neoplasms, Germ Cell and Embryonal 1Melanoma 1Gliosarcoma 1Gastrointestinal Neoplasms 1Epilepsy 1Ependymoma 1Craniopharyngioma 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Central Nervous System Carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Surgical Procedures, Operative 4Magnetic Resonance Spectroscopy 3Exenatide 3tocilizumab 2Temozolomide 2Surveys and Questionnaires 2Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2Donepezil 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trifluridine tipiracil drug combination 1trametinib 1tozuleristide 1tovorafenib 1temsirolimus 1gallium Ga 68 dotatate 1entinostat 1dabrafenib 1cobimetinib 1carboxyamido-triazole 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1anlotinib 1Verteporfin 1Vemurafenib 1Tumor Burden 1Transurethral Resection of Bladder 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Craniopharyngioma × Memantine × CNS × Clear all
NCT03194906 2023-07-13

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

St. Jude Children's Research Hospital

Phase 2 Completed
34 enrolled
CNS

Brain Neoplasms, Craniopharyngioma, Ependymoma, Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡